-Wall Street Journal Citing Government Spokesman
LifeMD Shares Undervalued: Analyst Initiates With Outperform Rating
Cantor Fitzgerald initiated coverage on LifeMD Inc (NASDAQ: LFMD) with an Overweight rating and a price target of $7,
Related Posts
Argus Research Downgrades Zoom Video Comms to Hold
Argus Research analyst Joseph Bonner downgrades Zoom Video Comms (NASDAQ:ZM) from Buy to Hold.
Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $82
Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $74 to $82.
Disney’s Dilemma With Star India Aggravated By Mukesh Ambani’s Cricket Moves: Report
This story was first published on the Benzinga India portal.